Tivicay
- Product NDC
- 70518-1487
- 11-digit product format
- 705181487
- Labeler code
- 70518
- Product ID
- 70518-1487_d9646621-c67e-490a-e053-2995a90a2a4e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- dolutegravir sodium
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- REMEDYREPACK INC.
- Application
- NDA204790
- Marketing category
- NDA
- Marketing start
- 2018-10-06
- Marketing end
- 0000-00-00
- Substance
- DOLUTEGRAVIR SODIUM
- Active strength
- 50 mg/1
- Pharmacologic classes
- HIV Integrase Inhibitors [MoA], Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC], Multidrug and Toxin Extrusion Transporter 1 Inhibitors [MoA], Organic Cation Transporter 2 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70518-1487-0 | 70518148700 | 30 TABLET, FILM COATED in 1 BLISTER PACK (70518-1487-0) | 2018-10-06 | 0000-00-00 | No | No | Current |